Retraction Note: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
Sci Rep. 2023 May 10;13(1):7592.
doi: 10.1038/s41598-023-34694-8.
1 Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, China.
2 Department of Emergency Medicine, the Second Affiliated Hospital, Southeast University, Nanjing, 210002, China.
3 Department of Respiratory Medicine, the First People's Hospital of Nantong, Nantong, 226000, China.
4 Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, China. yishi201607@163.com.